FDAnews Device Daily Bulletin

TRIMEDYNE MARKETS NEW PROSTATE LASER DEVICE

Sept. 7, 2005
A A

Trimedyne -- an Irvine, Ca.-based manufacturer of lasers and disposable fiber optic delivery devices for use in a variety of surgical applications including urology, orthopedics, ENT surgery, gynecology, GI surgery and general surgery -- announced recently that it has begun marketing its new VaporMAX Side-Firing Laser Device for treating benign prostatic hyperplasia, commonly referred to as an enlarged prostate.

Trimedyne claimed its device vaporizes tissue faster than other currently marketed side-firing laser devices, based on animal tissue laboratory testing and published data, minimizing procedure and operating room time. The company also claimed that testing has shown the new device to be more durable than others, enabling even large prostates to be treated with just one procedure.